Here are today’s cannabis briefs for March 19, 2018:
MedReleaf (MEDFF) announced that it entered into an agreement to become the largest supplier of medical cannabis products to Cannamedical Pharma GMBH, a leading medical cannabis distributor to pharmacies in Germany. According to a company statement, MedReleaf will provide Cannamedical with monthly exports of five of its premium strain varieties significantly improving the predictability and security of drug delivery to the German market. Sales to Germany will commence promptly upon the expected receipt of MedReleaf’s European Medical Agency Good Manufacturing Practices certification and export permit from Health Canada in the coming weeks.
Kona Gold Solutions, Inc.
Kona Gold announced its wholly owned subsidiary, HighDrate, LLC, is entering the Chicago market with its new CBD Energy Waters. The Company’s new distribution partner, 1 Oak Wholesale, based in Addison, IL, will distribute the Company’s HighDrate CBD Energy Waters in Chicago and surrounding areas. “Our new HighDrate CBD Energy Waters has hit the market with a splash with overwhelmingly positive feedback from customers and quick re-orders from our retailers around the country,” stated Robert Clark, CEO of Kona Gold Solutions, Inc. “I am very excited to announce our first distribution partner of our HighDrate CBD Energy Waters just three months after launch.”
True Leaf Medicine International Ltd.
True Leaf Medicine (TRLFF) has recruited two medicinal cannabis cultivation experts to lead the development of its medicinal cannabis products. Stephen Schroeder, Chief Cannabis Industry Advisor, and Christian Zofchak, Director of Horticulture Operations, have joined the True Leaf team, driven by a motivation to help patients, as well as their own family members, who find their pharmaceutical treatments ineffective or intolerable.
The cultivation team members are Canadian leaders in selective cannabis plant development. They will identify the best cannabis plant genetics worldwide, and, as part of True Leaf’s proprietary intellectual property, will develop unique strains capable of producing the active ingredients needed to develop a highly-effective medicinal product line to address neurological, musculoskeletal, gynaecological, and gastrointestinal conditions.
WeedMD (WDDMF) announced that it has made a strategic investment in Scorpion Resources Inc., to be renamed Blockstrain Technology Corp. WeedMD will be amongst the first federally-licensed producers to initiate the integration of blockchain technology into its ecosystem. Blockstrain delivers a secure and immutable blockchain platform to establish global certainty for cannabis strains and their ownership.
Canopy Growth Corporation
Canopy Growth confirmed that it has successfully completed a transfer of 1,500 cannabis clones to its Madrid -based partner, Alcaliber SA, completing the first phase of a partnership entered into by both parties as announced on September 11, 2017.